标签归档：reduced

Graphene oxide, reduced Cat. No. GO1-RD-1 100 mg修饰性聚乙二醇

发表于由

上海金畔生物科技有限公司提供各种分子量和基团修饰性聚乙二醇定制服务。

Graphene oxide, reduced

Cat. No. GO1-RD-1 Graphene oxide, reduced Cat. No. GO1-RD-1 100 mg
Specification
Unit Size 100 mg
Price $385.00

Qty Add to Cart

Description:

Nanocs provides various single layer graphene and graphene oxide products for your research use. These graphene products have been processed with multi step chemical and physical processes to ensure high quality.

Nanocs also provides various surface modified graphene and graphene oxide products with a wide range of specifications to suit different applications.

Product Specifications:

  • Composition: Single layer graphene oxide in aqueous solution, 2~5 mg/mL graphene oxide;
  • Flake Size: 0.5~5 microns;
  • Thickness: 1.1 nm. Single atomic layer over 80%;
  • Purity: Carbon contents around 75%, oxygen contents 35%;
  • Color: Pale yellow to dark brown.

Storage Conditions:

  • Store at 4 0C.

葡萄糖苷酸酶检测底物 Aldouronic Acid Mixture (Reduced) 货号：O-AMXR Megazyme试剂盒

发表于由
葡萄糖苷酸酶检测底物

英文名：Aldouronic Acid Mixture (Reduced)

货号：O-AMXR

规格：100 mg

市场价： 2800元

High purity Aldouronic Acids Mixture (NaBH4 Reduced) for use in research, biochemical enzyme assays and in vitro diagnostic analysis.

Contains a mixture of borohydride reduced aldobiouronic, aldotriouronic and aldotetraouronic and aldopentaouronic acids (10:60:20:10). Substrate for α-glucuronidase.

暂无问题解答

暂无视频

五糖（X3Glc4 – 硼氢化还原） Heptasaccharide Reduced 货号：O-X3G4R Megazyme试剂盒

发表于由
五糖（X3Glc4 – 硼氢化还原）

英文名：Heptasaccharide Reduced

货号：O-X3G4R

规格：50 mg

市场价： 2800元

CAS: 129865-03-8
Molecular Formula: C39H68O33
Molecular Weight: 1064.9
Purity: 95%

High purity Heptasaccharide (X3Glc4 – borohydride reduced) for use in research, biochemical enzyme assays and
in vitro diagnostic analysis.

暂无问题解答

暂无视频

木糖基纤维二糖 Xylosyl Cellobiose (reduced) 50mg 货号：O-XCBIR Megazyme试剂盒

发表于由
木糖基纤维二糖

英文名：Xylosyl Cellobiose (reduced) 50mg

货号：O-XCBIR

规格：50 mg

市场价： 2800元

CAS: 129865-02-7
Molecular Formula: C17H32O15
Molecular Weight: 476.4
Purity: > 95%

High purity Xylosyl-cellobiose (borohydride reduced) for use in research, biochemical enzyme assays and in vitro diagnostic analysis.

Potential substrate for α-xylosidase.

暂无问题解答

暂无视频

1,4-β-D-细胞试验（硼降低纤维三糖） 1,4-β-D-Cellotriitol (borohydride reduced cellotriose) 货号：O-CTRRD Megazyme试剂盒

发表于由
1,4-β-D-细胞试验（硼降低纤维三糖）

英文名：1,4-β-D-Cellotriitol (borohydride reduced cellotriose)

货号：O-CTRRD

规格：50 mg

市场价： 3000元

CAS: 61473-64-1
Molecular Formula: C18H34O16
Molecular Weight: 506.4
Purity: > 95%

High purity 1,4-β-D-Cellotriitol (borohydride reduced cellotriose) for use in research, biochemical enzyme assays and

in vitro diagnostic analysis.

Trisaccharides from hydrolysis of cellulose and borohydride reduced.

Store at room temperature.

暂无问题解答

暂无视频

1,4-β-D- Cellotetraitol（硼氢化还原纤维四糖） 1,4-β-D-Cellotetraitol (borohydride reduced cellotetraose) 货号：O-CTERD Megazyme试剂盒

发表于由
1,4-β-D- Cellotetraitol（硼氢化还原纤维四糖）

英文名：1,4-β-D-Cellotetraitol (borohydride reduced cellotetraose)

货号：O-CTERD

规格：50 mg

市场价： 3000元

CAS: 5548-55-0
Molecular Formula: C24H44O21
Molecular Weight: 668.6
Purity: > 95%

High purity 1,4-β-D-Cellotetraitol (borohydride reduced cellotetraose) for use in research, biochemical enzyme assays and in vitro diagnostic analysis.

Tetrasaccharides from hydrolysis of cellulose and borohydride reduced.

Store at room temperature.

暂无问题解答

暂无视频

1,4-β-D-Cellopentaitol (borohydride reduced cellopentaose) 1,4-β-D-Cellopentaitol (borohydride reduced cellopentaose) 货号：O-CPERD Megazyme试剂盒

发表于由
1,4-β-D-Cellopentaitol (borohydride reduced cellopentaose)

英文名：1,4-β-D-Cellopentaitol (borohydride reduced cellopentaose)

货号：O-CPERD

规格：30 mg

市场价： 3000元

CAS: 61473-65-2
Molecular Formula: C30H54O26
Molecular Weight: 830.7
Purity: > 95%

High purity 1,4-β-D-Cellopentaitol (borohydride reduced cellopentaose) for use in research, biochemical enzyme assays and in vitro diagnostic analysis.

Pentasaccharide from hydrolysis of cellulose and borohydride reduced.

Store at room temperature.

暂无问题解答

暂无视频

Gibco™ Opti-MEM™ I Reduced Serum Medium, GlutaMAX™

发表于由

上海金畔生物科技有限公司提供Gibco™ Opti-MEM™ I Reduced Serum Medium, GlutaMAX™ ，欢迎访问官网了解更多产品信息和订购。
Gibco™ Opti-MEM™ I Reduced Serum Medium, GlutaMAX™

详情介绍

Gibco™ Opti-MEM™ I Reduced Serum Medium, GlutaMAX™ Supplement

Opti-MEM™ I medium can be used with a variety of suspension and adherent mammalian cells, including Sp2, AE-1, CHO, BHK-21, HEK, and primary fibroblasts.                                                                                                      Using Opti-MEM™ I Medium：

Opti-MEM™ I Reduced-Serum Medium is a unique medium that contains insulin, transferrin, hypoxanthine, thymidine, and trace elements. These additional components allow for a reduction in serum supplementation by at least 50%. Opti-MEM™ I medium uses a sodium bicarbonate buffer system (2.4 g/L), and therefore requires a 5–10% CO2 environment to maintain physiological pH.


cGMP manufacturing and quality system：

Opti-MEM™ I is manufactured at a cGMP-compliant facility located in Grand Island, New York. The facility is registered with the FDA as a medical device manufacturer and is certified to ISO 13485 standards. For supply chain continuity, we offer an identical Opti-MEM™ I product made in our Scotland facility (51985-042). This facility is also registered with the FDA as a medical device manufacturer and certified to the ISO 13485 standard.

Gibco™ Opti-MEM™ Reduced Serum Medium, powder

发表于由

上海金畔生物科技有限公司提供Gibco™ Opti-MEM™ Reduced Serum Medium, powder ，欢迎访问官网了解更多产品信息和订购。
Gibco™ Opti-MEM™ Reduced Serum Medium, powder

详情介绍

Gibco™ Opti-MEM™ Reduced Serum Medium, powder

Gibco™ Opti-MEM™ is a unique media that contains insulin, transferrin, hypoxanthine, thymidine, and trace elements. These additional components allow for a reduction in serum supplementation by at least 50%.


cGMP Manufacturing and Quality System：

For supply chain continuity, we manufacture Gibco™ Opti-MEM™ at two separate facilities located in Grand Island, NY and Scotland, UK. Both sites are compliant with cGMP manufacturing requirements, are certified to ISO 13485, and are registered with the FDA as medical device manufacturers.


Gibco™ Opti-MEM™ uses a sodium bicarbonate buffer system (2.4 g/L) and therefore requires a 5-10% CO2 environment to maintain physiological pH.


Powder forms of Gibco™ cell culture medium require sodium bicarbonate supplementation, pH adjustment and filtration at the time of preparation


Gibco™ Opti-MEM™ I Reduced Serum Medium, no phenol

发表于由

上海金畔生物科技有限公司提供Gibco™ Opti-MEM™ I Reduced Serum Medium, no phenol ，欢迎访问官网了解更多产品信息和订购。
Gibco™ Opti-MEM™ I Reduced Serum Medium, no phenol

详情介绍

Gibco™ Opti-MEM™ I Reduced Serum Medium, no phenol red

Opti-MEM™ I medium can be used with a variety of suspension and adherent mammalian cells, including Sp2, AE-1, CHO, BHK-21, HEK, and primary fibroblasts.                                                                                                       Using Opti-MEM™ Reduced-Serum Medium：

Opti-MEM™ I medium is a unique medium that contains insulin, transferrin, hypoxanthine, thymidine, and trace elements. These additional components allow for a reduction in serum supplementation by at least 50%. Opti-MEM™ I medium uses a sodium bicarbonate buffer system (2.4 g/L), and therefore requires a 5–10% CO2 environment to maintain physiological pH.


cGMP manufacturing and quality system：

For supply chain continuity, we manufacture Opti-MEM™ Reduced-Serum Medium at two separate facilities located in Grand Island, NY and Scotland, UK. Both sites are compliant with cGMP manufacturing requirements, are certified to ISO 13485, and are registered with the FDA as medical device manufacturers.

Gibco™ Opti-MEM™|Reduced Serum Medium

发表于由

上海金畔生物科技有限公司提供Gibco™ Opti-MEM™|Reduced Serum Medium ，欢迎访问官网了解更多产品信息和订购。
Gibco™ Opti-MEM™|Reduced Serum Medium

详情介绍

Gibco™ Opti-MEM™|Reduced Serum Medium

Using Opti-MEM™ I Medium：

Opti-MEM™ I Reduced-Serum Medium is a unique medium that contains insulin, transferrin, hypoxanthine, thymidine, and trace elements. These additional components allow for a reduction in serum supplementation by at least 50%. Opti-MEM™ I medium uses a sodium bicarbonate buffer system (2.4 g/L), and therefore requires a 5–10% CO2 environment to maintain physiological pH.


cGMP manufacturing and quality system：

Opti-MEM™ I is manufactured at a cGMP-compliant facility located in Grand Island, New York. The facility is registered with the FDA as a medical device manufacturer and is certified to ISO 13485 standards. For supply chain continuity, we offer an identical Opti-MEM™ I product made in our Scotland facility (31985-047). This facility is also registered with the FDA as a medical device manufacturer and certified to the ISO 13485 standard.